Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PRVB - Is Provention Bio a Bad News Buy?

PRVB - Is Provention Bio a Bad News Buy?

Provention Bio Inc.

Sometimes the market overreacts to a negative development. Shares of Provention Bio (NASDAQ: PRVB) recently plunged after the FDA issued a Complete Response Letter for its diabetes drug teplizumab. In this Motley Fool Live video recorded on July 7 , Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not Provention Bio is now a bad news buy.

Continue reading

For further details see:

Is Provention Bio a Bad News Buy?
Stock Information
Company Name: Provention Bio Inc.
Stock Symbol: PRVB
Market: NASDAQ
Website: proventionbio.com
Menu
PRVB PRVB Quote PRVB Short PRVB News PRVB Articles PRVB Message Board
Get PRVB Alerts

News, Short Squeeze, Breakout and More Instantly...